Prenatal genetic diagnosis of Down's syndrome

Expert Review of Molecular Diagnostics

Volumn 2, Issue 6, 2002, Pages 605-615

  Abbott, Mary Alice ^a   Benn, Peter ^b  

^a Farmington   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Amniocentesis; Chorionic villus sampling; Comparative genomic hybridization; Cytogenitics; Down's syndrome; Fetal ultrasound; Fluorescence in situ hybridization; Maternal serum screening; PCR; Prenatal diagnosis

Indexed keywords

AMNIOCENTESIS; BIRTH DEFECT; CHORION VILLUS SAMPLING; CHROMOSOME ANALYSIS; DOWN SYNDROME; FETUS ECHOGRAPHY; GENETIC ANALYSIS; GENETIC DISORDER; HUMAN; MATERNAL AGE; MENTAL DEFICIENCY; MOLECULAR GENETICS; PRENATAL DIAGNOSIS; PRENATAL SCREENING; REVIEW; CHROMOSOME 21; DIAGNOSTIC PROCEDURE; ECHOGRAPHY; FEMALE; FETUS DISEASE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC SCREENING; GENETICS; METHODOLOGY; NUCLEIC ACID HYBRIDIZATION; PREGNANCY; PRENATAL DEVELOPMENT; TRISOMY;

ALPHA FETOPROTEIN; BIOLOGICAL MARKER;

ALPHA-FETOPROTEINS; AMNIOCENTESIS; BIOLOGICAL MARKERS; CHORIONIC VILLI SAMPLING; CHROMOSOMES, HUMAN, PAIR 21; DOWN SYNDROME; FEMALE; FETAL DISEASES; GENETIC SCREENING; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MATERNAL AGE; MOLECULAR DIAGNOSTIC TECHNIQUES; NUCLEIC ACID HYBRIDIZATION; PREGNANCY; PREGNANCY TRIMESTERS; PREIMPLANTATION DIAGNOSIS; PRENATAL DIAGNOSIS; TRISOMY; ULTRASONOGRAPHY, PRENATAL;

EID: 0036855209     PISSN: 14737159     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737159.2.6.605     Document Type: Review

References (78)

1. Egan JF, Benn P, Borgida AF, Rodis JF, Campbell WA, Vintzileos AM. Efficacy of screening for fetal Down's syndrome in the United States from 1974 to 1997. Obst. Gynecol. 96(6), 979-985 (2000). Documents the substantial changes in childbearing ages and the significance for Down's syndrome (DS) screening.
2. Elias S, Simpson JL, Bombard AT. Amniocentesis and fetal blood sampling. In: Genetic Disorders and the Fetus. Milunsky A (Ed.). Johns Hopkins University Press, Baltimore, USA, 53-82 (1998).
3. Brambati B, Tului L Prenatal genetic diagnosis through chorionic villus sampling. In: Genetic Disorders and the Fetus. Milunsky A (Ed.) Johns Hopkins University Press, Baltimore, USA, 150-178 (1998).
4. Cuckle HS, Wald NJ, Thompson SG. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum α-fetoprotein level. Br. J. Obstet. Gynaecol. 94(5), 387-402 (1987). Provides the maternal age-specific prevalence of DS used in many screening programs.
5. Cuckle H. Down's syndrome fetal loss rate in early pregnancy. Prenat. Diagn. 19(12), 1177-1179 (1999).
6. Benn PA, Egan JF. Survival of Down's syndrome in utero. Prenat. Diagn. 20(5), 432-433 (2000).
7. Morris JK, Wald NJ, Watt HC. Fetal loss in Down's syndrome pregnancies. Prenat. Diagn. 19(2), 142-145 (1999).
8. American College of Obstetricians and Gynecologists. Down's Syndrome Screening. ACOG Committee opinion no 141. Washington DC, USA (1994).
9. Tanski S, Rosengren SS, Benn PA. Predictive value of the triple screening test for the phenotype of Down's syndrome. Am. J. Med. Genet. 85(2), 123-126 (1999).
10. Benn PA, Collins R. Evaluation of effect of analytical imprecision in maternal serum screening for Down's syndrome. Ann. Clin. Biochem. 38(1), 28-36 (2001).
11. Benn PA. Advances in prenatal screening for Down's syndrome: I General principles and second trimester testing. Clin. Chim. Acta 323(1-2), 1-16 (2002). Recent review article.
12. Palomaki GE, Knight GJ, McCarthy JE, Haddow JE, Donhowe JM. Maternal serum screening for Down's syndrome in the United States: A 1995 survey. Am. J. Obstet. Gynecol. 176(5), 1046-1051 (1997).
13. Benn PA, Ying J, Beazoglou T, Egan JF. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down's syndrome and trisomy 18 with adjustment for cross-identification and double-positive results. Prenat. Diagn. 21(1), 46-51 (2001).
14. Wald NJ, Densem JW, Densem fW, George L, Muttukrishna S, Knight PG. Prenatal screening for Down's syndrome using inhibin-A as a serum marker. Prenat. Diagn. 16(2), 143-153 (1996).
15. Wald NJ, Densem JW, George L et al. Inhibin-A in Down's syndrome pregnancies: Revised estimate of standard deviation. Prenat Diagn. 17(3), 285-290 (1997).
16. Shipp TD, Benacerraf BR. Second trimester ultrasound screening for chromosomal abnormalities. Prenat. Diagn. 22(4), 296-307 (2002). Comprehensive review of ultrasound criteria used for the identification of DS-affected pregnancies.
17. Smith-Bindman R, Hosmer W, Feldstein VA, Deeks JJ, Goldberg JD. Second-trimester ultrasound to detect fetuses with Down's syndrome: A meta-analysis. JAMA 285(8), 1044-1055 (2001). Meta-analysis of 56 articles spanning almost 20 years that recorded second trimester ultrasound findings, karyotype and outcomes.
18. Nyberg DA, Souter VL. Sonographic markers for fetal trisomies: Second trimester. J. Ultrasound Med. 20(6), 655-674 (2001).
19. Nyberg DA, Souter VL, El-Bastawissi A, Young S, Luthhardt F, Luthy DA. Isolated sonographic markers for detection of fetal Down's syndrome in the second trimester of pregnancy. J. Ultrasound Med. 20(10), 1053-1063 (2001).
20. Souter VL, Nyberg DA, El-Bastawissi A, Zebelman A, Luthhardt F, Luthy DA. Correlation of ultrasound findings and biochemical markers in the second trimester of pregnancy in fetuses with trisomy 21. Prenat. Diagn. 22(3), 175-182 (2002).
21. Benn PA, Kaminsky LM, Ying J, Borgida AF, Egan JF. Combined second trimester biochemical and ultrasound screening for Down's syndrome. Obstet Gynecol. 100(5), (2002) (In Press). Use of a screening strategy that integrates ultrasound findings with serum screening to produce a combined risk is presented.
22. Chen J, Heffley D, Beazoglou T, Benn P. Utilization of amniocentesis by women screening positive for Down's syndrome on the second-trimester triple test. Commun. Genet. 3(1), 24-30 (2000).
23. De Graaf IM, Tijmstra T, Bleker OP, Van Lith JM. Womens' preference in Down's syndrome screening. Prenat. Diagn. 22(7), 624-629 (2002).
24. Szabó J, Gellén J. Nuchal fluid accumulation in trisomy-21 detected by vaginosonography in first trimester. Lancet 336(8723), 1133 (1990).
25. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 352(9125), 343-346 (1998). Substantial demonstration of first trimester screening using nuchal translucency.
26. Wald NJ, Kennard A, Hackshaw A, McGuire A. Antenatal screening for Down's syndrome. J. Med. Screen. 4(4), 181-246 (1997).
27. Cuckle HS, Van Lith JM. Appropriate biochemical parameters in first-trimester screening for Down's syndrome. Prenat. Diagn. 19(6), 505-512 (1999). This meta-analysis determined the theoretical efficacy of a first trimester screening approach.
28. Benn PA. Advances in prenatal screening for Down's syndrome: II First trimester testing and future directions. Clin. Chim. Acta 324(1-2), 1-11 (2002). Recent review article.
29. Haddow JE. Antenatal screening for Down's syndrome: Where are we and where next? Lancet 352(9125), 336-337 (1998).
30. Hyett JA. Increased nuchal translucency in fetuses with a normal karyotype. Prenat. Diagn. 22(4), 864-868 (2002).
31. Spencer K, Spencer CE, Power M, Moakes A, Nicolaides KH. One stop clinic for assessment of risk for fetal anomalies: A report of the first year of prospective screening for chromosomal anomalies in the first trimester. Br. J. Obstret. Gynaecol. 107(10), 1271-1275 (2000). Documents the success of a first trimester screening protocol.
32. Beazoglou T, Heffley D, Kyriopoulos J, Vintzileos A, Benn P. Economic evaluation of prenatal screening for Down's syndrome in the USA. Prenat. Diagn. 18(12), 1241-1252 (1998),
33. Wald NJ, Watt HC, Hackshaw AK. Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters. N. Engl. J. Med. 341(7), 461-467 (1999).
34. Copel JA, Bahado-Singh RO. Prenatal screening for Down's syndrome - A search for the family's values. N. Engl. J. Med. 341(7), 521-522 (1999).
35. Cuckle H. Integrating antenatal Down's syndrome screening. Curr. Opin. Obst. Gynecol. 13(2), 175-181 (2001).
36. Toone JR, Applegarth DA, Vallance HD, Wilson RD. Early amniocentesis for biochemical genetic prenatal diagnosis. Lancet 351(9110), 1207-1208 (1998).
37. Rooney D. Human Cytogenetics: Constitutional Analysis Oxford, UK, (2001).
38. Strom CM, Levin R, Strom S, Masciangelo C, Kuliev A, Verlinsky Y. Neonatal outcome of preimplantation genetic diagnosis by polar body removal: The first 109 infants. Pediatr. 106(4), 650-653 (2000). This follow-up report demonstrates the clinical utility of preimplantation genetic diagnosis (PGD).
39. Elias S. Preimplantation genetic diagnosis by comparative genomic hybridization. N. Engl. J. Med. 345(21), 1569-1571 (2001).
40. Papers from the 8th annual meeting of the International Working Group on Preimplantation Genetics, in association with the 9th International Conference on Prenatal Diagnosis and Therapy. CA, USA, J. Assist. Reprod. Genet. 16(4), 161-220 (1999).
41. De Vos A, Van Steirteghem A. Aspects of biopsy procedures prior to preimplantation genetic diagnosis. Prenat. Diagn. 21(9), 767-780 (2001).
42. Blancato JK. Fluorescence in situ hybridization. In: The Principles of Clinical Cytogenetics. Gersen SL, Keagle MB (Eds), NJ, USA, 449-453 (1999).
43. Witters I, Devriendt K, Legius E et al. Rapid prenatal diagnosis of trisomy 21 in 5049 consecutive uncultured amniotic fluid samples by fluorescence in situ hybridisation (FISH). Prenat. Diagn. 22(1), 29-33 (2002).
44. Tepperberg J, Pettenati MJ, Rao PN et al. Prenatal diagnosis using interphase fluorescence in situ hybridization (FISH): 2-Year multi-center retrospective study and review of the literature. Prenat. Diagn. 21(4), 293-301 (2001).
45. Technical and clinical assessment of fluorescence in situ hybridization: An ACMG/ASHG position statement. I. Technical considerations. Test and Technology Transfer Committee. Genet. Med. 2(6), 356-361 (2000).
46. Wilton L. Preimplantation genetic diagnosis for aneuploidy screening in early human embryos: a review. Prenat. Diagn. 22(6), 512-518 (2002).
47. Toth T, Findlay I, Papp C et al. Prenatal detection of trisomy 21 and 18 from amniotic fluid by quantitative fluorescent polymerase chain reaction. J. Med. Genet. 35(2), 126-129 (1998).
48. Pertl B, Kopp S, Kroisel PM, Tului L, Brambati B, Adinolfi M. Rapid detection of chromosome aneuploidies by quantitative fluorescence PCR: First application on 247 chorionic villus samples. J. Med. Genet. 36(4), 300-303 (1999).
49. Miny P, Tercanli S, Holzgreve W. Developments in laboratory techniques for prenatal diagnosis. Curr. Opin. Obstet. Gynecol. 14(2), 161-168 (2002).
50. Bili C, Divane A, Apessos A et al. Prenatal diagnosis of common aneuploidies using quantitative fluorescent PCR. Prenat. Diagn. 22(5), 360-365 (2002).
51. Verma L, Macdonald F, Leedham P, McConachie M, Dhanjal S, Hulten M. Rapid and simple prenatal DNA diagnosis of Down's syndrome. Lancet 352(9121), 9-12 (1998).
52. Eiben B, Trawicki W, Hammans W. Rapid prenatal diagnosis of aneuploidies in uncultured amniocytes by fluorescence in situ hybridization (FISH) - Evaluation of >3000 cases. Fetal Diagn. 18, 901-916 (1999).
53. Schmidt W, Jenderny J, Hecher K et al. Detection of aneuploidy in chromosomes X, Y, 13, 18 and 21 by QF-PCR in 662 selected pregnancies at risk. Mol. Hum. Reprod. 6(9), 855-860 (2000).
54. Wilton L, Williamson R, McBain J, Edgar D, Voullaire L. Birth of a healthy infant after preimplantation confirmation of euploidy by comparative genomic hybridization. N. Engl. J. Med. 345(21), 1537-1541 (2001). Successful PGD by analyzing a single cell by Comparative genomic hybridization (CGH).
55. Lomax B, Tang S, Separovic E et al. Comparative genomic hybridization with flow cytometry improves results of cytogenetic analysis of spontaneous abortions. Am. J. Hum. Genet. 66(5), 1516-1521 (2000).
56. Lapierre JM, Cacheux V, Luton D et al. Analysis of uncultured amniocytes by comparative genomic hybridization: A prospective prenatal study. Prenat. Diagn. 20(2), 123-131 (2000).
57. Wessendorf S, Fritz B, Wrobel G et al. Automated screening for genomic imbalances using matrix-based comparative genomic hybridization. Lab. Invest. 82(1), 47-60 (2002). Describes innovations necessary for microarray technologies to emerge into clinical practice.
58. Voullaire L, Wilton L, Slater H, Williamson R. Detection of aneuploidy in single cells using comparative genomic hybridization. Prenat. Diagn. 19(9), 846-851 (1999).
59. Wells D, Sherlock JK, Handyside AH, Delhanty JD. Detailed chromosomal and molecular genetic analysis of single cells by whole genome amplification and comparative genomic hybridisation. Nucleic Acids Res. 27(4), 1214-1218 (1999). Noninvasive prenatal diagnostic strategies may require this type of technology.
60. Solinas-Toldo S, Lampel S, Stilgenbauer S et al. Matrix-based comparative genomic hybridization: Biochips to screen for genomic imbalances. Genes Chromos. Cancer 20(4), 399-407 (1997).
61. Pinkel D, Segraves R, Sudar D et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nature Genet. 20(2), 207-211 (1998).
62. Zhang X, Niebuhr E, Snijders A et al. Association of Cri du Chat phenotype with DNA copy number abnormalities measured by array CGH. American Society for Human Genetics Annual Meeting. CA, USA, (2001).
63. Lamvu G, Kuller JA. Prenatal diagnosis using fetal cells from the maternal circulation. Obstet. Gynecol. Surv. 52(7), 433-437 (1997). Review article.
64. Bianchi DW. Prenatal diagnosis by analysis of fetal cells in maternal blood. J. Pediatr. 127(6), 847-856 (1995).
65. Bianchi DW, Simpson JL, Jackson LG et al. Fetal gender and aneuploidy detection using fetal cells in maternal blood: Analysis of NIFTY I data. Prenat. Diagn. 22(7), 609-615 (2002). Results of the first attempts at noninvasive prenatal diagnosis.
66. Zhong XY, Burk MR, Troeger C, Jackson LR, Holzgreve W, Hahn S. Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses. Prenat. Diagn. 20(10), 795-798 (2000).
67. Bianchi DW. Fetal cells in the maternal circulation: Feasibility for prenatal diagnosis. Br. J. Haematol. 105(3), 574-583 (1999).
68. Daryani YP, Barker GH, Penna LK, Patton MA. Transcervical sampling as a means of detection of fetal cells during the first trimester of pregnancy. Am. J. Obstet. Gynecol. 183(3), 752-754 (2000).
69. Ishai D, Amiel A, Diukman R et al. Uterine cavity lavage: Adding FISH to conventional cytogenetics for embryonic sexing and diagnosing common chromosomal aberrations. Prenat. Diagn. 15(10), 961-965 (1995).
70. Fejgin MD, Diukman R, Cotton Y, Weinstein G, Amiel A, Fetal cells in the uterine cervix: A source for early non-invasive prenatal diagnosis. Prenat. Diagn. 21(8), 619-621 (2001).
71. Chang SD, Lin SL, Chu KK, Hsi BL. Minimally-invasive early prenatal diagnosis using fluorescence in situ hybridization on samples from uterine lavage. Prenat. Diagn. 17(11), 1019-1025 (1997).
72. Pretorius DH, Borok NN, Coffler MS, Nelson TR. Three-dimensional ultrasound in obstetrics and gynecology. Radiologic. Clin. N. Am. 39(3), 499-521 (2001).
73. Michailidis GD, Economides DL, Schild RL. The role of three-dimensional ultrasound in obxstetrics. Curr. Opin. Obstet. Gynecol. 13(2), 207-214 (2001).
74. Biesecker LG. The end of the beginning of chromosome ends. Am. J. Med. Genet. 107(4), 263-266 (2002). Reviews chromosome imbalances involving chromosome telomeres.
75. Carpenter NJ. Molecular cytogenetics. Semin. Pediatr. Neurol. 8(3), 135-146 (2001). Review article.
76. American College of Medical Genetics. http://www.acmg.net/Pages/ACMG_Activities/policy_statements_ pages/current/Multiple_Marker_Screening_in_Women_35_and_Older_ Position_Statement_on.asp
77. First and Second Trimester Evaluation of the Risk of Aneuploidy. (Viewed October 2002) http://clinicaltrials.gov/show/NCT00006445
78. Royal College of Obstetricians and Gynecologists. Recommendations Arising from the Study Group on Screening for Down's Syndrome in the First Trimester. www.rcog.org.uk/study/downsyndrome.html